Discover 1,621 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,621
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Durham NC, Huntersville NC, Fairfax VA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase1, Recruiting
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
for
Solid Tumors, GI Cancer
Location: Durham NC, Washington DC, Baltimore MD, Boston MA,
Sponsor: Curegenix Inc.
Sex: All
Age: 18+
Code: NCT02675946
Phase1, Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Durham NC, Washington D.C. DC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 3 - 39
Code: NCT05096481
Phase2, Recruiting
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
for
Relapsed/Refractory Acute Myeloid Leukemia (AML),
Location: Durham NC, Atlanta GA, New York NY, Buffalo NY,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT05143996
Phase1, Recruiting
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
for
Solid Tumors
Location: Durham NC, Atlanta GA, Toronto, Boston MA, St Louis MO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05203172
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
for
Acute Myelogenous Leukemia
Location: Durham NC, Augusta GA, Houston TX, Albuquerque NM,
Sponsor: Hybrigenics Corporation
Sex: All
Age: 65+
Code: NCT02802267
Phase2, Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: Durham NC, Raleigh NC, Norfolk VA, Fairfax VA,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT05659381
Phase3, Recruiting
Optimizing Surgical Decisions in Young Adults With Breast Cancer
for
Breast Cancer Stage 0, Breast Cancer Stage I,
Location: Durham NC, New York NY, New Haven CT, Boston MA
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18 - 44
Code: NCT06275126
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Location: Durham NC, Richmond VA, Hershey PA, Atlanta GA,
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT03567889
Phase3, Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
for
Prostate Cancer
Location: Durham NC, Chapel Hill NC, Charlottesville VA,
Sponsor: Prostate Cancer Clinical Trials Consortium
Sex: Male
Age: 21+
Code: NCT03151629
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Durham NC, Morrisville NC, Roanoke VA, Norfolk VA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase3, Recruiting
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
for
Brain Tumor, Primary, Brain Metastases, Adult
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT05480644
Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Durham NC, Chesapeake VA, Fairfax VA, Philadelphia PA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase2, Recruiting
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
for
Ovarian Cancer, Advanced Ovarian Carcinoma,
Location: Durham NC, Boston MA, Aurora CO, Boulder CO
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 18+
Code: NCT06710548
Recruiting
KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models
for
Cancer, Predictive Cancer Model, Effects of Chemotherapy
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Known Medicine, Inc.
Sex: All
Age: 18+
Code: NCT05338073
Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Durham NC, Fairfax VA, Washington D.C. DC,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase1, Phase2, Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Durham NC, Chapel Hill NC, Washington D.C. DC,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase3, Recruiting
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors